Coexistence of anti-glomerular basement membrane disease and IgA nephropathy: an illustrative case and comprehensive literature review

References

• Bharati J, Yang Y, Sharma P, et al. Atypical anti-glomerular basement membrane disease. Kidney Int Rep. 2023;8(6):1–9. doi: 10.1016/j.ekir.2023.03.010.
   PubMed Web of Science ®Google Scholar
• Matsuno T, Okumura T. Anti-glomerular basement membrane disease after diagnosis of immunoglobulin a nephropathy: a case report. Cureus. 2023;15(5):e39737. doi: 10.7759/cureus.39737.
   PubMed Web of Science ®Google Scholar
• Zhao J, Yan Y, Cui Z, et al. The immunoglobulin G subclass distribution of anti-GBM autoantibodies against rHalpha3(IV)NC1 is associated with disease severity. Hum Immunol. 2009;70(6):425–429. doi: 10.1016/j.humimm.2009.04.004.
   PubMed Web of Science ®Google Scholar
• Borza DB, Chedid MF, Colon S, et al. Recurrent goodpasture’s disease secondary to a monoclonal IgA1-kappa antibody autoreactive with the alpha1/alpha2 chains of type IV collagen. Am J Kidney Dis. 2005;45(2):397–406. doi: 10.1053/j.ajkd.2004.09.029.
   PubMed Web of Science ®Google Scholar
• Revert F, Merino R, Monteagudo C, et al. Increased goodpasture antigen-binding protein expression induces type IV collagen disorganization and deposit of immunoglobulin a in glomerular basement membrane. Am J Pathol. 2007;171(5):1419–1430. doi: 10.2353/ajpath.2007.070205.
   PubMed Web of Science ®Google Scholar
• Horita S, Nitta K, Honda K, et al. A case of IgA nephropathy with split reduction of alpha5(V) chain of type IV collagen in glomerular basement membrane. Nephron. 1998;80(4):482–483. doi: 10.1159/000045228.
   PubMed Web of Science ®Google Scholar
• Ghohestani RF, Rotunda SL, Hudson B, et al. Crescentic glomerulonephritis and subepidermal blisters with autoantibodies to alpha5 and alpha6 chains of type IV collagen. Lab Invest. 2003;83(5):605–611. doi: 10.1097/01.lab.0000067497.86646.4d.
   PubMed Web of Science ®Google Scholar
• Shen CR, Jia XY, Cui Z, et al. Clinical and immunological characteristics of patients with combined anti-glomerular basement membrane disease and IgA nephropathy. Clin Kidney J. 2023;16(9):1480–1488. doi: 10.1093/ckj/sfad068.
   PubMed Web of Science ®Google Scholar
• Qu W, Liu N, Xu T, et al. Case report: coexistence of anti-glomerular basement membrane disease, membranous nephropathy, and IgA nephropathy in a female patient with preserved renal function. Front Pharmacol. 2022;13(13):e876512. doi: 10.3389/fphar.2022.876512.
   PubMedGoogle Scholar
• Longano A. Concurrent anti-GBM disease and IgA glomerulonephritis. Pathology. 2019;51(3):336–338. doi: 10.1016/j.pathol.2018.09.065.
   PubMed Web of Science ®Google Scholar
• Noor SM, Abuazzam F, Mathew R, et al. IgA nephropathy: a review of existing and emerging therapies. Front Nephrol. 2023;3:1175088. doi: 10.3389/fneph.2023.1175088.
   PubMedGoogle Scholar
• Trpkov K, Abdulkareem F, Jim K, et al. Recurrence of anti-GBM antibody disease twelve years after transplantation associated with de novo IgA nephropathy. Clin Nephrol. 1998;49(2):124–128.
   PubMed Web of Science ®Google Scholar
• Yu C, Yanbei S, Hua Z, et al. A case of anti-glomerular basement membrane disease accompanied with IgA nephropathy. Chin Clin Res. 2023;36(05):758–759.
   Google Scholar
• Guo C, Ye M, Li S, et al. Anti-glomerular basement membrane disease with IgA nephropathy: a case report. World J Clin Cases. 2022;10(12):3916–3922. doi: 10.12998/wjcc.v10.i12.3916.
   PubMed Web of Science ®Google Scholar
• Chen H, Jin J, Cheng MJ, et al. High-frequency plasma exchange therapy for immunocompromised, type I crescentic glomerulonephritis complicated with IgA nephropathy: a case report and literature review. Medicine (Baltimore). 2023;102(3):e32698. doi: 10.1097/MD.0000000000032698.
   PubMed Web of Science ®Google Scholar
• Shaojie F, Sensen S, Jingda H, et al. Great prognosis of concurrent anti-GBM disease and IgA nephropathy in a young woman: a case report. Medicine (Baltimore). 2022;101(37):e30686. doi: 10.1097/MD.0000000000030686.
   PubMed Web of Science ®Google Scholar
• Bajaj V, Thakur S, Barwad A, et al. IgA nephropathy and atypical anti-GBM disease: a rare dual pathology in a pediatric rapidly progressive glomerulonephritis. Glomerular Dis. 2021;2(1):54–57. doi: 10.1159/000521582.
   PubMedGoogle Scholar
• Zhang M, Yang D, Wang W, et al. Pneumocystis pneumonia secondary to intensive immunosuppression treatment for anti-GBM disease complicated with IgA nephropathy: a case report and literature review. Medicine (Baltimore). 2021;100(45):e27728. doi: 10.1097/MD.0000000000027728.
   PubMed Web of Science ®Google Scholar
• Khor C, Wong MG, Reagh J. Anti-glomerular basement membrane disease and IgA nephropathy in a patient with previous renal cell carcinoma. BMJ Case Rep. 2021;14(7):e236555. doi: 10.1136/bcr-2020-236555.
   PubMedGoogle Scholar
• Malviya PB, Modigonda S, Maitra S, et al. Anti-glomerular basement membrane disease with atypical associations. Saudi J Kidney Dis Transpl. 2021;32(1):227–231. doi: 10.4103/1319-2442.318529.
   PubMed Web of Science ®Google Scholar
• Suh KS, Choi SY, Bae GE, et al. Concurrent anti-glomerular basement membrane nephritis and IgA nephropathy. J Pathol Transl Med. 2019;53(6):399–402. doi: 10.4132/jptm.2019.08.05.
   PubMed Web of Science ®Google Scholar
• Kojima T, Hirose G, Komatsu S, et al. Development of anti-glomerular basement membrane glomerulonephritis during the course of IgA nephropathy: a case report. BMC Nephrol. 2019;20(1):25. doi: 10.1186/s12882-019-1207-3.
   PubMedGoogle Scholar
• Gupta Y, Swain M, Gowrishankar S. Anti-glomerular basement membrane disease combined with IgA nephropathy. Indian J Nephrol. 2019;29(5):375–377. doi: 10.4103/ijn.IJN_309_18.
   PubMed Web of Science ®Google Scholar
• Jing S, Ruihai H, Zhifang H, et al. A case of anti-glomerular basement membrane disease accompanied with IgA nephropathy with abdominal distension as the first symptom. People’s Military Surgeon. 2018;61(03):265–266.
   Google Scholar
• Annamalai I, Chandramohan G, Srinivasa Prasad ND, et al. Rapidly progressive glomerulonephritis due to anti-glomerular basement membrane disease accompanied by IgA nephropathy: an unusual association. Saudi J Kidney Dis Transpl. 2017;28(6):1404–1407. doi: 10.4103/1319-2442.220866.
   PubMedGoogle Scholar
• Xu D, Wu J, Wu J, et al. Novel therapy for anti-glomerular basement membrane disease with IgA nephropathy: a case report. Exp Ther Med. 2016;11(5):1889–1892. doi: 10.3892/etm.2016.3149.
   PubMed Web of Science ®Google Scholar
• Ge YT, Liao JL, Liang W, et al. Anti-glomerular basement membrane disease combined with IgA nephropathy complicated with reversible posterior leukoencephalopathy syndrome: an unusual case. Am J Case Rep. 2015;16:849–853. doi: 10.12659/ajcr.894619.
   PubMed Web of Science ®Google Scholar
• Weifeng S, Di W, Shuwang G, et al. One case report of IgA nephropathy complicated with anti-glomerular basement membrane disease and literature review. J Internal Intensive Med. 2015;21(01):40–43.
   Google Scholar
• Yamaguchi H, Takizawa H, Ogawa Y, et al. A case report of the anti-glomerular basement membrane glomerulonephritis with mesangial IgA deposition. CEN Case Rep. 2013;2(1):6–10. doi: 10.1007/s13730-012-0029-y.
   PubMedGoogle Scholar
• Wang A, Wang Y, Wang G, et al. Mesangial IgA deposits indicate pathogenesis of anti-glomerular basement membrane disease. Mol Med Rep. 2012;5(5):1212–1214.
   PubMed Web of Science ®Google Scholar
• Bixia G, Mingxi L, Wenli X, et al. Anti-glomerular basement membrane disease accompanied with IgA nephropathy: a case report and literature. J Beijing Med. 2009;31(03):185–187.
   Google Scholar
• Cui Z, Zhao MH, Wang SX, et al. Concurrent anti-glomerular basement membrane disease and immune complex glomerulonephritis. Ren Fail. 2006;28(1):7–14. doi: 10.1080/08860220500461195.
   PubMed Web of Science ®Google Scholar
• Yan W, Liping Z, Lin Y, et al. A case of antiglomerular basement membrane disease accompanied with IgA nephropathy. Chin J Nephrol. 2005;09:501.
   Google Scholar
• Philip R, Dumont A, Martin Silva N, et al. ANCA and anti-glomerular basement membrane double-positive patients: a systematic review of the literature. Autoimmun Rev. 2021;20(9):102885. doi: 10.1016/j.autrev.2021.102885.
   PubMed Web of Science ®Google Scholar
• Bu L, Said SM, Herrera Hernandez L, et al. The characteristics of concurrent anti-glomerular basement membrane nephritis and membranous nephropathy. Kidney Int Rep. 2023;8(10):2164–2167. doi: 10.1016/j.ekir.2023.07.031.
   PubMed Web of Science ®Google Scholar
• Kantauskaitė M, Laučytė-Cibulskienė A, Miglinas M. Histopathological classification – a prognostic tool for rapidly progressive glomerulonephritis. Medicina (Kaunas). 2018;54(2):17. doi: 10.3390/medicina54020017.
   PubMed Web of Science ®Google Scholar
• Maliakkal JG, Hicks MJ, Michael M, et al. Renal survival in children with glomerulonephritis with crescents: a pediatric nephrology research consortium cohort study. J Clin Med. 2020;9(8):2385. doi: 10.3390/jcm9082385.
   PubMed Web of Science ®Google Scholar
• Chen Z, Xu J, Wu J, et al. Prognostic analysis of crescentic glomerulonephritis with acute kidney injury: a single-center cohort with 5-year follow-up. Int Urol Nephrol. 2022;54(9):2375–2383. doi: 10.1007/s11255-022-03111-w.
   PubMed Web of Science ®Google Scholar
• Cui Z, Zhao J, Jia XY, et al. Anti-glomerular basement membrane disease: outcomes of different therapeutic regimens in a large single-center Chinese cohort study. Medicine (Baltimore). 2011;90(5):303–311. doi: 10.1097/MD.0b013e31822f6f68.
   PubMed Web of Science ®Google Scholar
• Yang R, Hellmark T, Zhao J, et al. Levels of epitope-specific autoantibodies correlate with renal damage in anti-GBM disease. Nephrol Dial Transplant. 2009;24(6):1838–1844. doi: 10.1093/ndt/gfn761.
   PubMed Web of Science ®Google Scholar
• Zhao J, Cui Z, Yang R, et al. Anti-glomerular basement membrane autoantibodies against different target antigens are associated with disease severity. Kidney Int. 2009;76(10):1108–1115. doi: 10.1038/ki.2009.348.
   PubMed Web of Science ®Google Scholar
• Masuda Y, Yamanaka N, Ishikawa A, et al. Glomerular basement membrane injuries in IgA nephropathy evaluated by double immunostaining for α5(IV) and α2(IV) chains of type IV collagen and low-vacuum scanning electron microscopy. Clin Exp Nephrol. 2015;19(3):427–435. doi: 10.1007/s10157-014-1008-8.
   PubMed Web of Science ®Google Scholar
• Cui Z, Wang HY, Zhao MH. Natural autoantibodies against glomerular basement membrane exist in normal human sera. Kidney Int. 2006;69(5):894–899. doi: 10.1038/sj.ki.5000135.
   PubMed Web of Science ®Google Scholar
• Bowman C, Ambrus K, Lockwood CM. Restriction of human IgG subclass expression in the population of auto-antibodies to glomerular basement membrane. Clin Exp Immunol. 1987;69(2):341–349.
   PubMed Web of Science ®Google Scholar
• Qu Z, Cui Z, Liu G, et al. The distribution of IgG subclass deposition on renal tissues from patients with anti-glomerular basement membrane disease. BMC Immunol. 2013;14(1):19. doi: 10.1186/1471-2172-14-19.
   PubMedGoogle Scholar
• Couser WG, Baker PJ, Adler S. Complement and the ­direct mediation of immune glomerular injury: a new perspective. Kidney Int. 1985;28(6):879–890. doi: 10.1038/ki.1985.214.
   PubMed Web of Science ®Google Scholar
• Otten MA, Groeneveld TW, Flierman R, et al. Both complement and IgG fc receptors are required for development of attenuated anti-glomerular basement membrane nephritis in mice. J Immunol. 2009;183(6):3980–3988. doi: 10.4049/jimmunol.0901301.
   PubMed Web of Science ®Google Scholar
• Ma R, Cui Z, Liao YH, et al. Complement activation contributes to the injury and outcome of kidney in human anti-glomerular basement membrane disease. J Clin Immunol. 2013;33(1):172–178. doi: 10.1007/s10875-012-9772-2.
   PubMed Web of Science ®Google Scholar
• Hart SP, Jackson C, Kremmel LM, et al. Specific binding of an antigen-antibody complex to apoptotic human neutrophils. Am J Pathol. 2003;162(3):1011–1018. doi: 10.1016/S0002-9440(10)63895-3.
   PubMed Web of Science ®Google Scholar
• Kovalenko P, Fujinaka H, Yoshida Y, et al. Fc receptor-mediated accumulation of macrophages in crescentic glomerulonephritis induced by anti-glomerular basement membrane antibody administration in WKY rats. Int Immunol. 2004;16(5):625–634. doi: 10.1093/intimm/dxh058.
   PubMed Web of Science ®Google Scholar
• Ohlsson S, Herlitz H, Lundberg S, et al. Circulating anti-glomerular basement membrane antibodies with predominance of subclass IgG4 and false-negative immunoassay test results in anti-glomerular basement membrane disease. Am J Kidney Dis. 2014;63(2):289–293. doi: 10.1053/j.ajkd.2013.08.032.
   PubMed Web of Science ®Google Scholar
• Cui Z, Zhao MH, Singh AK, et al. Antiglomerular basement membrane disease with normal renal function. Kidney Int. 2007;72(11):1403–1408. doi: 10.1038/sj.ki.5002525.
   PubMed Web of Science ®Google Scholar
• Antonelou M, Henderson SR, Bhangal G, et al. Binding truths: atypical anti-glomerular basement membrane disease mediated by IgA anti-glomerular basement membrane antibodies targeting the α1 chain of type IV collagen. Kidney Int Rep. 2018;4(1):163–167. doi: 10.1016/j.ekir.2018.08.005.
   PubMed Web of Science ®Google Scholar